Project Details
Description
AI-driven nanoparticle development for in situ expression of bispecific T-cell engager (BiTE) therapy for advanced epithelial ovarian cancer
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/25 → 5/31/26 |
Funding
- MINNESOTA OVARIAN CANCER ALLIANCE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.